Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal

BACKGROUND: Induction chemotherapy (ICT) is supposed to reduce the risk of micrometastatic progression and improve resectability of non-small cell lung cancer (NSCLC). However, best indications for ICT strategy remain unclear in published meta-analyses. Based on this observation, an evaluation of da...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabre, Elizabeth, Rivera, Caroline, Mordant, Pierre, Gibault, Laure, Dujon, Antoine, Foucault, Christophe, Le Pimpec-Barthes, Françoise, Riquet, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632925/
https://www.ncbi.nlm.nih.gov/pubmed/26557911
http://dx.doi.org/10.1111/1759-7714.12250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632925/
https://www.ncbi.nlm.nih.gov/pubmed/26557911
http://dx.doi.org/10.1111/1759-7714.12250

Ejemplares similares